Public Sector Health Plan Cost Containment: International Procedure Pricing
SchoolCare (NH) assessed $30 million across 65 districts in September 2025. The NJ State Health Benefits Plan for Local Governments implemented a 37% premium increase and was declared structurally unstable by the state Treasury Department. Howard County (MD) Public Schools saw GLP-1 pharmaceutical costs increase from $485,000 to $3.6 million in two years. Government plans are ERISA-exempt, providing more benefit design flexibility than private-sector plans.
Public Sector Healthcare Expenditure Trends, 2023-2026
Public sector health plan cost acceleration is documented across multiple states and plan types. The NJ State Health Benefits Plan for Local Governments was declared "structurally unstable and financially unsustainable" by the state Treasury Department in May 2025, with a 37% premium increase for 2025 and projected cumulative increases reaching 60% by 2029. Over 70 local government employers have exited the SHBP since 2020 (NJ Monitor). Hampshire County (MA) Group Insurance Trust saw pharmaceutical claims increase 80% in 18 months, draining reserves from $20 million to under $5 million, driven primarily by GLP-1 medication utilisation.
North Carolina's State Health Plan went from a $1 billion surplus to a $500 million deficit projected to reach $1.3 billion by 2027 (NC Treasurer's Office). Vermont school districts now allocate 15% of total budgets to healthcare, trending toward 20% (VTDigger, 2026). Champlain Valley School District eliminated 82 staff positions and $9 million over two budget cycles to absorb healthcare cost increases. SchoolCare (NH) assessed $30 million across 65 districts following catastrophic claims and speciality medication costs, with individual district bills ranging from $1,000 to $2 million (Londonderry: $2M, Concord: $1.9M).
The cost drivers are consistent with national commercial trends: cancer treatment, cardiovascular procedures, musculoskeletal surgery, and speciality pharmaceuticals (particularly GLP-1 receptor agonists). Public sector plans face these same cost drivers with an additional structural constraint: funding is tied to tax revenue and legislative appropriation cycles that do not adjust in real time to healthcare cost acceleration.
GLP-1 Expenditure Trends and Surgical Alternatives: A Cost Comparison
GLP-1 receptor agonists (semaglutide, tirzepatide) cost $936 to $1,350 per month at US list pricing, or $11,000 to $16,000 per patient per year on an ongoing basis. Howard County (MD) Public Schools documented GLP-1 expenditure growth from $485,000 to $3.6 million in two years. A Minnesota school district reported GLP-1s accounting for 2% of prescriptions but 56% of total drug spending. Multiple public entities have restricted or eliminated weight-loss GLP-1 coverage in 2025-2026: Howard County Schools, Massachusetts state employees (GIC), Hampshire County Trust, HealthTrust (NH), and Boston's municipal plan.
Bariatric surgery at JCI-accredited international facilities costs $3,900 to $7,000 as a one-time procedure (Mexico, Turkey; iFHP 2024). A 2024 JAMA Surgery cost-effectiveness analysis found that bariatric surgery produces greater long-term weight loss than GLP-1 receptor agonists and reaches cost parity with ongoing drug therapy within 6 to 8 months. The American College of Surgeons published corroborating findings. For a school district with 50 members on GLP-1s at $11,000 per year ($550,000 annually), bariatric surgery for the same cohort at international pricing represents a one-time expenditure of $195,000 to $350,000 with break-even under 8 months.
Domestic Centers of Excellence Adoption in State Plans
State government health plans are adopting domestic centres of excellence programmes at an accelerating rate. North Carolina partnered with Lantern in October 2025, covering 550,000 active members across 1,500+ non-emergency surgical procedures at published rates 55% below commercial averages. Complication rates are documented below 1% versus a national average of 8-15%. Bariatric surgery became mandatory through Lantern as of January 2026. The State Employees Association of NC characterised the programme as "a huge win for state employees and all taxpayers."
Tennessee selected Carrum Health in April 2025 for musculoskeletal, cardiac, cancer, and substance use treatment. Maine has operated a Carrum programme since 2019; Nevada since 2023. Carrum's RAND Corporation-evaluated outcomes document 45% savings per surgical episode, 80% reduction in readmissions, and 30% of referrals redirected to conservative care. Oregon implemented reference-based pricing at 200% of Medicare for hospital reimbursement, saving $112.7 million in the first 27 months (NASHP). Financial penalties for entities exceeding cost benchmarks begin in 2026.
International published pricing extends the savings range beyond domestic COE. Domestic programmes document approximately 45% savings per episode (RAND, 2022). International JCI-accredited facilities publish pricing at 60-80% below US commercial equivalents for the same procedure categories. For plans already operating domestic COE programmes, international pricing represents an additional tier of cost reduction on procedures that exceed what domestic bundled arrangements can offer.
Marketplace Infrastructure for Public Entities
For public entities, the marketplace requires no procurement process because no public funds are expended. JCI or equivalent nationally accredited international providers list procedures with published pricing. Plan members browse 1,954 procedures, compare pricing across providers and countries, and book consultations directly with the facility they select. There is no clinical intermediary, care coordination, or episode management. A benefits committee decision to include the resource in member materials is typically sufficient.
Providers pay Sylk Health a commission on completed treatment. The commission is drawn from provider revenue and is not added to the member's price. No fee is charged to the plan sponsor. No subscription, per-member charge, implementation fee, or contract is required. Because no public funds are expended, no procurement process is triggered. The marketplace can be made available to plan members by including a reference in existing member resources.
The plan sponsor determines independently whether and how to incentivise member utilisation. Common structures include cost-sharing waivers at international facilities, travel cost coverage for the member and a companion, and shared savings arrangements. These are plan design decisions controlled by the public entity, independent of the marketplace infrastructure.
| Procedure | US Commercial Price | International Price Examples | US Source | Int'l Source |
|---|---|---|---|---|
| Bariatric Surgery (Gastric Sleeve) | $15,000 - $35,000 | Mexico $3,900 | Turkey $5,500 | India $5,000 | ASMBS 2024 | iFHP 2024 |
| Hip Replacement (Total) | $40,000 - $177,000 | India $7,200 | Mexico $14,000 | Colombia $12,000 | Trilliant 2025 | iFHP 2024 |
| Knee Replacement (Total) | $30,000 - $75,000 | India $6,600 | Turkey $10,400 | Mexico $12,000 | KFF/CostHelper | iFHP 2024 |
| Cardiac Bypass (CABG) | $70,000 - $150,000 | India $7,900 | Colombia $11,200 | Turkey $13,900 | iFHP 2024 | iFHP 2024 |
| Spinal Fusion (Single Level) | $80,000 - $150,000 | India $10,300 | Mexico $15,400 | Thailand $14,000 | PLOS ONE 2024 | iFHP 2024 |
Sources: iFHP 2024, World Population Review 2025, OECD Health at a Glance 2025.
School District and Municipal Consortium Structures
School district health insurance consortiums operate small risk pools vulnerable to individual catastrophic claims. SchoolCare (NH) covers approximately 65 districts and 25 other public employers. A small number of catastrophic claims and speciality medication costs drained $10 million in reserves in a single year, triggering the $30 million assessment. This structural vulnerability (small pool, concentrated risk, limited diversification) is the defining characteristic of school district health financing and the primary reason these entities face the most acute version of the public sector cost crisis.
Consortiums and municipal pools can make the marketplace available to all member entities through a single governance decision. Because there is no cost and no contract, individual procurement by each member district is not required. Nebraska's Educators Health Alliance covers nearly every school district in the state through a single governance structure. The Connecticut MEHIP, Arkansas Municipal Health Benefit Programme, and Illinois LGHP operate similarly. A single board action gives all participating entities access to the published pricing data.
Legal Framework: ERISA Exemption and Benefit Design Authority
Government plans established by states, political subdivisions, or their agencies are fully exempt from ERISA Titles I and IV. This exemption removes federal fiduciary standards, federal reporting requirements (Form 5500), and federal preemption of state law. In practical application, government plans have more benefit design flexibility than private-sector ERISA plans. There is no federal prohibition on including international providers in covered facility definitions. Federal employee plans already cover international care: the Blue Cross Federal Employee Programme maintains international provider networks, and the Foreign Service Benefit Plan covers all providers outside the US at in-network rates with 400+ direct billing arrangements.
Self-funded governmental plans are also largely exempt from state insurance mandates, which typically apply to "insurance" products rather than self-funded arrangements. This creates maximum flexibility for benefit design, including international provider access. ACA requirements (minimum essential coverage, non-discrimination rules, mental health parity) continue to apply. The controlling factor is the plan document, and the governing body of the public entity (school board, city council, county commission, state plan board) controls that document.
Frequently Asked Questions
A government health plan is a plan established by a state, political subdivision (county, municipality, school district), or their agencies for their employees. Under 29 USC 1003(b)(1), government plans are fully exempt from ERISA Titles I and IV. This exemption removes federal fiduciary standards, Form 5500 reporting, and ERISA preemption of state law. Government plans have broad benefit design flexibility, subject to ACA requirements and applicable state regulations. Federal employee plans, including the Foreign Service Benefit Plan, already maintain international provider arrangements.
The marketplace operates on a provider-funded model with no expenditure by the plan sponsor. Because no public funds are expended, no budget line is created, no appropriation is needed, and no competitive bid process is triggered. The marketplace functions as an informational resource available to plan members. A benefits committee decision or administrative action to include the reference in member materials is typically sufficient. No contract between Sylk Health and the public entity is required.
Government plans (established by states, political subdivisions, or their agencies) are fully exempt from ERISA Titles I and IV. This exemption provides government plans with more benefit design flexibility than private-sector ERISA plans, not less. There is no federal prohibition on covering international care. Federal employee plans already do so: the Foreign Service Benefit Plan maintains 400+ direct billing arrangements with international providers. Self-funded governmental plans have maximum benefit design authority, subject to ACA requirements and applicable state regulations.
Providers pay Sylk Health a commission on completed treatment from their own revenue. No fee is charged to the plan sponsor, its members, or its advisors. No subscription, per-member charge, implementation fee, or contract is required. If no members access the marketplace, the plan has expended nothing. If members do access it, they find published procedure pricing at 40-80% below domestic commercial equivalents at JCI-accredited facilities.
Health insurance consortiums and municipal pools can make the marketplace available to all member entities through a single governance decision. Because there is no cost and no contract, no individual RFP from each member entity is required. The consortium board votes to include the resource in member communications. All participating municipalities, school districts, or counties gain access. Nebraska's Educators Health Alliance and Connecticut's MEHIP are examples of structures where a single governance action covers dozens of member entities.
Adding a voluntary, additive resource at no cost to the plan or its members occupies the strongest legal position relative to collective bargaining obligations. The resource does not replace domestic coverage, does not increase member cost-sharing, and is entirely optional. In states without public sector collective bargaining (North Carolina, Virginia, Texas, Tennessee), the plan can add it unilaterally. North Carolina added the Lantern domestic COE programme without union objection; the State Employees Association of NC characterised it as 'a huge win for state employees and all taxpayers.'
Specialist complication insurance is available from underwriters including Global Protective Solutions at $500 to $1,500 per procedure. Coverage extends up to 180 days post-procedure and includes medical costs, emergency evacuation, extended hospitalisation, and companion travel. The plan sponsor can include complication coverage as part of the benefit incentive design. JCI-accredited facilities demonstrate 25-30% fewer adverse events than non-accredited facilities (BMJ Quality and Safety). Sylk Health has no clinical involvement before, during, or after treatment.
Carrum Health and Lantern are domestic centres of excellence programmes that administer surgical episodes with bundled payments, clinical coordination, and outcomes guarantees. They charge the plan per episode and require contractual arrangements. Sylk Health is marketplace infrastructure: published international pricing that members access independently. It carries no cost to the plan and requires no contract. The two serve different functions and are complementary. North Carolina uses Lantern for domestic mandatory bariatric referrals; international pricing data serves a separate function (voluntary member access to published pricing across broader procedure categories).
GLP-1 receptor agonists (semaglutide, tirzepatide) cost $936 to $1,350 per month ($11,000 to $16,000 per year) on an ongoing basis. Bariatric surgery at JCI-accredited international facilities costs $3,900 to $7,000 as a one-time procedure. According to a 2024 JAMA Surgery cost-effectiveness analysis, bariatric surgery produces greater long-term weight loss than GLP-1 receptor agonists and reaches cost parity within 6 to 8 months. Howard County (MD) Public Schools documented GLP-1 expenditure growth from $485,000 to $3.6 million over two years.
Published Pricing: 1,954 International Procedures
Pricing data from JCI-accredited international facilities, organised by procedure category.
Sylk Health operates an online marketplace listing JCI or equivalent nationally accredited international healthcare providers. Sylk Health is not a healthcare provider, insurance company, health plan, or clinical service. Sylk Health does not provide medical advice, coordinate care, arrange travel, or manage clinical outcomes. All providers listed on the marketplace are independent entities. Patients contract directly with providers. Provider-listed prices are published by the providers themselves and may change without notice. Sylk Health does not set, verify, or guarantee provider pricing. Actual costs depend on individual case complexity, provider selection, and treatment requirements. Content on this page is for informational purposes only and does not constitute medical, legal, actuarial, or fiduciary advice. Plan administrators, carriers, and healthshare ministries should consult their own qualified advisors before making decisions based on information presented here. Sylk Health has no affiliation with any third-party organisation referenced on this page unless explicitly stated.